Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 585

1.

The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy.

Miller JF, Sadelain M.

Cancer Cell. 2015 Apr 13;27(4):439-449. doi: 10.1016/j.ccell.2015.03.007. Epub 2015 Apr 6. Review.

PMID:
25858803
2.

Repeating spatial activations in human entorhinal cortex.

Miller JF, Fried I, Suthana N, Jacobs J.

Curr Biol. 2015 Apr 20;25(8):1080-5. doi: 10.1016/j.cub.2015.02.045. Epub 2015 Apr 2.

PMID:
25843029
3.

Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction states.

Ge P, Scholl D, Leiman PG, Yu X, Miller JF, Zhou ZH.

Nat Struct Mol Biol. 2015 Mar 30. doi: 10.1038/nsmb.2995. [Epub ahead of print]

PMID:
25822993
4.

Targeted diversity generation by intraterrestrial archaea and archaeal viruses.

Paul BG, Bagby SC, Czornyj E, Arambula D, Handa S, Sczyrba A, Ghosh P, Miller JF, Valentine DL.

Nat Commun. 2015 Mar 23;6:6585. doi: 10.1038/ncomms7585.

5.

Correction: A new topology of the HK97-like fold revealed in Bordetella bacteriophage by cryoEM at 3.5 Å resolution.

Zhang X, Guo H, Jin L, Czornyj E, Hodes A, Hui WH, Nieh AW, Miller JF, Zhou ZH.

Elife. 2015 Mar 18;4. doi: 10.7554/eLife.07482. No abstract available.

6.

The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice.

Sarikonda G, Sachithanantham S, Miller JF, Pagni PP, Coppieters KT, von Herrath M.

J Autoimmun. 2015 May;59:61-6. doi: 10.1016/j.jaut.2015.02.003. Epub 2015 Mar 13.

PMID:
25772283
7.

BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in vitro differentiation into functional Foxp3+ T regulatory cells.

Sarikonda G, Fousteri G, Sachithanantham S, Miller JF, Dave A, Juntti T, Coppieters KT, von Herrath M.

PLoS One. 2014 Nov 13;9(11):e112242. doi: 10.1371/journal.pone.0112242. eCollection 2014.

8.

Revisiting thymus function.

Miller JF.

Front Immunol. 2014 Aug 28;5:411. doi: 10.3389/fimmu.2014.00411. eCollection 2014. Review. No abstract available.

9.

Characterization and analysis of the Burkholderia pseudomallei BsaN virulence regulon.

Chen Y, Schröder I, French CT, Jaroszewicz A, Yee XJ, Teh BE, Toesca IJ, Miller JF, Gan YH.

BMC Microbiol. 2014 Aug 1;14:206. doi: 10.1186/s12866-014-0206-6.

10.

The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infection.

Balaji K, French CT, Miller JF, Colicelli J.

Traffic. 2014 Nov;15(11):1206-18. doi: 10.1111/tra.12204. Epub 2014 Sep 4.

11.

Type three secretion system-mediated escape of Burkholderia pseudomallei into the host cytosol is critical for the activation of NFκB.

Teh BE, French CT, Chen Y, Chen IG, Wu TH, Sagullo E, Chiou PY, Teitell MA, Miller JF, Gan YH.

BMC Microbiol. 2014 May 6;14:115. doi: 10.1186/1471-2180-14-115.

12.

Bordetella pertussis pathogenesis: current and future challenges.

Melvin JA, Scheller EV, Miller JF, Cotter PA.

Nat Rev Microbiol. 2014 Apr;12(4):274-88. doi: 10.1038/nrmicro3235. Epub 2014 Mar 10. Review.

13.

The Type VI secretion system spike protein VgrG5 mediates membrane fusion during intercellular spread by pseudomallei group Burkholderia species.

Toesca IJ, French CT, Miller JF.

Infect Immun. 2014 Apr;82(4):1436-44. doi: 10.1128/IAI.01367-13. Epub 2014 Jan 13.

14.

CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.

Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller JF, Wesley JD, Cadag E, Chae J, Ganesan L, Mallios R, Edelman S, Peters B, von Herrath M.

J Autoimmun. 2014 May;50:77-82. doi: 10.1016/j.jaut.2013.12.003. Epub 2013 Dec 30.

PMID:
24387802
15.

A new topology of the HK97-like fold revealed in Bordetella bacteriophage by cryoEM at 3.5 A resolution.

Zhang X, Guo H, Jin L, Czornyj E, Hodes A, Hui WH, Nieh AW, Miller JF, Zhou ZH.

Elife. 2013 Dec 17;2:e01299. doi: 10.7554/eLife.01299.

16.

Neural activity in human hippocampal formation reveals the spatial context of retrieved memories.

Miller JF, Neufang M, Solway A, Brandt A, Trippel M, Mader I, Hefft S, Merkow M, Polyn SM, Jacobs J, Kahana MJ, Schulze-Bonhage A.

Science. 2013 Nov 29;342(6162):1111-4. doi: 10.1126/science.1244056.

17.

Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.

Leivers M, Miller JF, Chan SA, Lauchli R, Liehr S, Mo W, Ton T, Turner EM, Youngman M, Falls JG, Long S, Mathis A, Walker J.

J Med Chem. 2014 Mar 13;57(5):1964-75. doi: 10.1021/jm401337x. Epub 2013 Nov 23.

PMID:
24224729
18.

Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment.

Sarikonda G, Pettus J, Sachithanantham S, Phatak S, Miller JF, Ganesan L, Chae J, Mallios R, Edelman S, Peters B, von Herrath M.

PLoS One. 2013 Nov 4;8(11):e79383. doi: 10.1371/journal.pone.0079383. eCollection 2013.

19.

Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehyde.

Bowman RK, Brown AD, Cobb JH, Eaddy JF, Hatcher MA, Leivers MR, Miller JF, Mitchell MB, Patterson DE, Toczko MA, Xie S.

J Org Chem. 2013 Dec 6;78(23):11680-90. doi: 10.1021/jo4014595. Epub 2013 Nov 13.

PMID:
24171666
20.

The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.

Ziegler AI, Le Page MA, Maxwell MJ, Stolp J, Guo H, Jayasimhan A, Hibbs ML, Santamaria P, Miller JF, Plebanski M, Silveira PA, Slattery RM.

Diabetologia. 2013 Dec;56(12):2659-68. doi: 10.1007/s00125-013-3038-2. Epub 2013 Sep 8.

PMID:
24013782
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk